Clinical Trials Browser

INDUSTRY × Malignant Solid Tumor × Paclitaxel × Clear all

NCT01515306 2022-03-08

A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors

Phase 2 Completed

48 enrolled 17 charts

Other solid neoplasm

Malignant Solid Tumor